DEUTSCHE BANK AG\ - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 41 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$90,191
+517.0%
15,235
+673.4%
0.00%
Q2 2023$14,617
-92.8%
1,970
-92.5%
0.00%
Q4 2020$204,000
-55.7%
26,166
-45.0%
0.00%
Q3 2020$461,00047,5990.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Corton Capital Inc. 13,966$103,0000.13%
Delphia (USA) Inc. 14,226$105,0000.12%
Sentinus, LLC 22,500$166,0000.10%
Intrepid Financial Planning Group LLC 20,000$148,0000.08%
PERRITT CAPITAL MANAGEMENT INC 12,000$89,0000.06%
J. Goldman & Co LP 148,738$1,098,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 88,966$657,0000.02%
EMFO, LLC 1,666$12,0000.01%
Virtu Financial LLC 12,590$93,0000.01%
Jump Financial, LLC 23,400$173,0000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders